← Back to Search

iSTEP for HIV/AIDS

N/A
Waitlist Available
Led By Brook L Henry, Ph.D.
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will examine the effect of a mobile phone text message intervention on people living with HIV, in terms of physical activity, diet, and risk factors for cardiovascular disease and neurocognitive performance.

Eligible Conditions
  • HIV/AIDS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diet History Questionnaire (DHQ)
Physical activity - steps per day
Secondary outcome measures
Brief Visuospatial Memory Test - Revised
C-reactive protein (CRP)
Carotenoids in plasma
+23 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: iSTEP PA interventionExperimental Treatment1 Intervention
Participants will wear a Fitbit and receive interactive daily text messages that are designed to motivate moderate physical activity (PA) and reduce sedentary behavior, including setting weekly goals to increase average daily step counts.
Group II: iSTEP PA and diet interventionExperimental Treatment1 Intervention
Participants will wear a Fitbit and receive interactive daily text messages that are designed to motivate moderate physical activity (PA), reduce sedentary behavior, and promote adherence to a Mediterranean-style diet. Participants will also be administered diet counseling from a registered dietitian and receive weekly feedback on both physical activity and diet behaviors.
Group III: Control ArmActive Control1 Intervention
Participants will wear a Fitbit but will not receive any additional elements of the iSTEP intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iSTEP
2018
N/A
~100

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,307 Total Patients Enrolled
Brook L Henry, Ph.D.Principal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any prospective participants being welcomed into this trial?

"Correct, according to clinicaltrials.gov this trial is actively enrolling participants. It was first advertised on December 1st 2018 and its details were last adjusted on July 19th 2022."

Answered by AI

To what extent has this clinical trial been embraced by participants?

"Affirmative. According to the clinicaltrials.gov registry, recruitment for this medical trial is ongoing since it was first posted back on December 1st 2018 and last edited July 19th 2022. The study seeks 150 participants from a single research location."

Answered by AI

What key goals are being pursued by this medical experiment?

"This six-month study seeks to measure the efficacy of a Diet History Questionnaire (DHQ). Secondary metrics include measuring for Tumor necrosis factor alpha, Total cholesterol, and D-dimer levels in plasma."

Answered by AI
~14 spots leftby Apr 2025